Why Pharmaceutical Drugs Industry Consultants Matter in India
India is at a very crucial juncture for its pharmaceutical drugs industry. Its current status as the world’s third largest producer of drugs by volume, with more than 20% of the supply of generic drugs to the rest of the world, and as an exporter of pharmaceutical products valued at more than US$ 30 billion a year to over 200 countries, makes it a major contributor to the global drug industry. This is a shocking figure that has led to a corresponding explosion of demand for expert advice — especially from the best pharmaceutical drugs industry consultants in India who are assisting the entrepreneur, MSME, and investor by making opportunities turn into reality.
Establishment of a pharmaceutical manufacturing unit in India is not an easy industrial activity. In contrast to many other manufacturing industries, pharma requires a combination of rigorous regulatory compliance, advanced process engineering, sophisticated quality systems compliant with global standards like WHO-GMP and US FDA norms and a thorough understanding of the chemistry and formulation science of active pharmaceutical ingredients (APIs). This complexity is a costly and risky bet for a first-generation entrepreneur or an MSME owner thinking of venturing into the segment without a knowledgeable consulting partner.
That is why the best pharmaceutical drugs industry consultants in India are in demand — they range from those who create process flow diagrams for the pharmaceutical technology to those who are responsible for getting turnkey drug manufacturing plants built. The right company for the job is the deciding factor for any project, whether it’s an API manufacturing unit, a pharmaceutical formulations facility or a bulk drug intermediates facility.
This article covers all aspects of the consulting industry and the role played by consultants working in the pharma industry, how to assess and shortlist the right consulting firms, and some advice for entrepreneurs who are thinking of doing a pharma project in India. All market data mentioned are from public information sources like IBEF, Invest India, and Government of India, Department of Pharmaceuticals among others.
Get Detailed Insights from This Book: Drugs & Pharmaceutical Technology Handbook
What Pharmaceutical Plant and Process Consultants Actually Do
There are numerous specialisation areas within pharmaceutical consulting. For any project owner, it is important to understand these differences. One of the most basic services is the Detailed Project Report (DPR). It is a detailed techno-economic report covering the manufacturing process, plant layout, raw material sourcing, machinery specifications, manpower planning, working capital requirements, and financial returns. The DPR is not a mere ritual or obligation. It is essential for banks and NBFCs when sanctioning loans. It also helps investors make informed investment decisions.
Process engineering consultants are more technical than beyond the DPR. They develop the production processes – synthesis of active pharmaceutical ingredients (APIs), establish multi-product API reactors, draw up formulation lines and formulate standard operating procedures (SOPs) compliant with CDSCO and Schedule M requirements. These consultants draw process flow diagrams (PFDs) and piping and instrumentation diagrams (P&IDs) for pharma technology projects, laying the engineering foundation of the plant.
The project goes further downstream with EPC (Engineering, procurement and construction) consultants. They are responsible for the selection of vendors, are onsite to oversee plant construction, coordinate civil and utility infrastructure, and may even offer commissioning support. Without an in-house engineering team, a well-qualified EPC consultant can significantly minimize project execution risk and shorten project time to commissioning.
Regulatory consultants are dedicated to acquiring the requisite licenses and permits, such as drug manufacturing licenses from state drug controllers under the Drugs and Cosmetics Act, NOC from the State Pollution Control Board and manufacturing authorisations from the Central Drugs Standard Control Organisation (CDSCO). For export units, regulatory consultants also support and assist entrepreneurs with WHO-GMP prequalification, US FDA/EMA (European Medicines Agency) compliance and COPP (Certificate of Pharmaceutical Product) documentation.
Finally, boutique management consulting firms in India provide higher level strategic advisory – market entry analysis, M&A due diligence, structuring a business plan for PE/VC investors, and growth strategy for established pharma companies. All these specialisations create the pharmaceutical drugs industry consulting ecosystem in India.
Why India Has Become a Global Hub for Pharmaceutical Drugs Consulting
Multiple factors have catapulted India to become one of the most dynamic pharmaceutical manufacturing hubs in the world, and consequently one of the most lucrative markets for leading pharmaceutical drugs industry consultants.
The Government of India’s Production Linked Incentive (PLI) scheme for pharmaceuticals has an outlay of ₹15,000 crore. It has helped promote large-scale domestic production of bulk drugs, APIs, and finished drugs. At the same time, the ₹6,940 crore PLI scheme for critical Key Starting Materials (KSMs) and drug intermediates aims to reduce India’s reliance on API imports from China. These policy ‘signals’ have generated a flood of new project enquiries. Entrepreneurs must now have access to the right pharma plant consultant to translate these incentives into viable business plans.
Another strong growth catalyst is importing substitution. India has been importing large quantities of KSMs and drug intermediates from China in the past. The strategic design of the PLI scheme to promote domestic API manufacturing has inspired MSME entrepreneurs, existing formulation companies and new investors to consider API manufacturing projects. Many of these projects are being undertaken for the first time. Process plant consultants and pharmaceutical technology specialists play a key role in educating these stakeholders about the chemistry, capex needs and process complexities.
Further, the global pharmaceutical supply chain has realigned since COVID. This shift has boosted India’s generic medicines supply chain. As a result, India has become a top choice globally. According to Invest India, India’s pharmaceutical exports reached around US$ 30.4 billion in FY 2024–25. The USA and Europe were the major markets. This export trend continues to generate regular demand for regulatory consulting, quality systems advising, and feasibility studies for plant expansions. These are the core services offered by the best pharmaceutical industry consultants in Delhi and across India.
The Indian Drug Manufacturers Association (IDMA) and the Indian Pharmaceutical Alliance (IPA) are active and involved in interfacing with the Government on all policy issues pertaining to the industry. Their membership programs and advocacy efforts are indicative of a more matured and organized sector ready to accept new members, as long as they are well prepared.
Get Detailed Project Report (DPR): Active Pharmaceutical Ingredient (API) Manufacturing
How to Evaluate and Shortlist the Best Pharmaceutical Drugs Industry Consultants in India
With dozens of firms claiming expertise in pharmaceutical consulting, choosing the right partner demands systematic evaluation. Here are the key criteria that experienced entrepreneurs and project financiers use.
1. Domain Expertise in Pharmaceutical Technology
Pharma manufacturing is highly specialised industry. A consultant may know food or chemical processing well. However, they may not have expertise in API synthesis, tablet formulation, or sterile manufacturing. Ensure that the consulting company has pharmaceutical technology experts. These experts should have experience in pharmacy, pharmaceutical sciences, or chemical engineering focused on drug manufacturing. They may also have expertise in regulatory affairs. Specifically, ask about their experience with your project’s dosage form or API class. This may include oral solids, injectables, APIs, bulk drug intermediates, or biopharmaceuticals.
2. Track Record in DPR and Feasibility Report Preparation
The DPR is the cornerstone document for any pharma project. Assess the consultant’s feasibility report by asking for references from bankers or investors. These references should be from projects financed using the consultant’s report. Review the consultant’s track record in market demand analysis and realistic capacity planning. Also check their accuracy in capital cost estimation and financial projections. The financials should be capable of passing lender scrutiny. Process plant consultants may have greater credibility than generic management consultants. This is especially true if they have assisted in loan sanctions for pharmaceutical manufacturing projects worth ₹10 crore to ₹200 crore.
3. Regulatory Knowledge — CDSCO, Schedule M, and State Drug Licensing
In the pharma consulting world, regulatory know-how is a must-have. The most knowledgeable pharmaceutical plant consultants are familiar with the Drugs and Cosmetics Act and the licensing procedures set by the state drug controllers and also the Good Manufacturing Practice (GMP) standards laid down in the schedule M of the Drugs and Cosmetics Act. The consultant needs to be aware of WHO-GMP certification and CDSCO export approvals as well as the regulatory requirements of the target export markets as applicable in export projects.
Apart from the drug specific regulations, pharmaceutical manufacturing units need to obtain environmental clearances from State Pollution Control Board, Factory act registration, GST compliance and MSME Registration for accessing benefits under various MSME schemes. OPPI also has to publish industry codes and compliance guidelines for manufacturing units, especially for formulation companies, to which they are expected to adhere.
4. Engineering and EPC Capability
The consultant’s expertise in managing or coordinating EPC tasks is a great benefit for entrepreneurs who are planning to build a greenfield pharmaceutical plant. The best engineering consultancy firms in India with a Pharma specialization can offer or take care of plant layout designs, HVAC, purified water, clean steam, equipment selection and vendor negotiation and construction supervision for the plant. The capability seamlessly integrates and mitigates the risk of project delays and cost overruns due to coordination gaps.
5. Client Base and Geographic Reach
A consulting company that works on projects for patients throughout India (not just one pharma cluster) will have added market exposure and a diversified project portfolio. Also, check the experience of consultants with existing drug manufacturing centers like Puducherry, Ahmedabad, Hyderabad, Aurangabad, or Baddi. This geographic exposure provides the consultant with an understanding of the regulatory sensitivities and nuances in the state, infrastructure requirements and incentives associated with new pharmaceutical units.
Related Article: Top Pharmaceutical Industry Consultants in India: A Practical Guide for Entrepreneurs
Role of NPCS in Pharmaceutical Drugs Project Consultancy
Founded in 1994, Niir Project Consultancy Services (NPCS), Delhi based Pharmaceutical Drugs Project Consultancy Company, www.niir.org, has a wide range of experience in project consulting for the pharmaceutical drugs industry in India. NPCS, having been in the business for more than 30 years, has delivered more than 150,000 projects successfully with clients spread across 85 countries, has a unique role in the Pharma project consultancy scenario in India.
NPCS’ main focus of pharmaceutical consulting services is the preparation of Detailed Project Reports (DPRs) and Techno-economic Feasibility Studies (TEFS) for various pharmaceutical manufacturing projects including API manufacturing, bulk drug manufacturing, drug intermediate manufacturing, formulations (tablets, capsules, injectables, syrups), fine chemicals, and speciality pharma chemicals. Every DPR includes manufacturing process design and process flow diagrams, machinery identification, raw material identification, market research and demand analysis, plant size calculations, product mix suggestions, and detailed financials of the project such as capital investment estimates, revenue projections and profitability analysis.
For investors looking at several pharma projects at once (which is a common scenario for entrepreneurs entering multiple new projects in the pharmaceutical industry), NPCS has a large collection of online drug project profiles, fine chemical project profiles, bulk drug intermediate project profiles, drug API ingredient project profiles, Drug intermediate project profiles, and Speciality pharmaceutical chemistry project profiles. The catalogue, which is available on NPCS Pharmaceutical Project Profiles, enables project owners to compare pre-scoped pharmaceutical project opportunities before embarking on a full feasibility study.
One of the key strengths of NPCS is its hands-on and bottom-line thinking approach to pharmaceutical technology consulting. The Feasibility Reports at NPCS are not theoretical but are based on real world manufacturing data, process engineering insights and India specific regulatory and infrastructure knowledge. This approach has become a benchmark for pharma entrepreneurs, MSME business planners, banks for due diligence and NRI investors for the pharmaceutical manufacturing investments in India.
Like any consultancy, due diligence is advised and entrepreneurs should look at NPCS published project profiles, view sample reports available on the internet, and fit the scope of the engagement to their project needs prior to requesting a complete DPR.
Best Pharmaceutical Drugs Industry Consultants in Delhi and India’s Pharma Consulting Landscape
Delhi and the National Capital Region (NCR) is the nerve centre of the industrial consulting industry in India. One of the biggest advantages the best pharmaceutical drugs industry consultant in Delhi have is their proximity to the central government ministries, such as the headquarters of the Centre for Drugs Standardization and Control (CDSCO) at FDA Bhawan, Kotla Road as well as the Department of Pharmaceuticals. This proximity is crucial for regulatory approvals, policy interpretations, and information regarding licensing inquiries.
Pharma consultants in Delhi also have easy access to India’s biggest financial and banking infrastructure. Most pharma project financing decisions are made here, especially for SME-scale projects. If you are an entrepreneur seeking loans from PSU Banks, NBFCs, or State Financial Corporations, a local consultant can be highly useful. They can interact with banks and assist with loan approvals, document submissions, and required revisions. This makes the entire financing process easier, especially for entrepreneurs based in Delhi.
The broader India consultancy firm ecosystem has also seen the entry of boutique management consulting firms specialising in life sciences. These firms typically complement the technical consulting done by process plant consultants, adding business intelligence, competitive benchmarking, investor presentation services, and growth strategy to the mix. For pharmaceutical projects exceeding ₹50 crore, a two-consultant approach — one technical, one strategic — is increasingly common among sophisticated project developers.
Explore proven business ideas with high success potential
Types of Pharmaceutical Drugs Consulting Services: A Comparative Overview
The table below maps each consultant type to its core focus, key deliverables, and the best-fit client profile.
| Type of Consultant | Core Focus Area | Key Deliverables | Best-Fit Client |
| Techno-Economic Feasibility Consultant | Market research, project sizing, financial modelling | Detailed Project Report (DPR), IRR/NPV analysis | First-generation entrepreneurs, banks, PE investors |
| Process Engineering Consultant | Manufacturing process design, process flow optimisation | PFDs, P&IDs, process validation reports | Pharma startups, MSME units scaling up capacity |
| Regulatory & Compliance Consultant | CDSCO licensing, GMP compliance, Schedule M upgrades | Regulatory dossiers, SOP frameworks, audit readiness | New drug manufacturers, export-focused units |
| EPC / Turnkey Project Consultant | End-to-end plant engineering, procurement, construction | Turnkey plant commissioning, vendor qualification | Mid-to-large pharmaceutical manufacturing units |
| API & Bulk Drug Project Consultant | Active Pharmaceutical Ingredient manufacturing, API park development | API process design, PLI scheme advisory, technology sourcing | Entrepreneurs targeting domestic API import substitution |
| Boutique Management Consulting Firm | Business strategy, market entry, M&A advisory in pharma | Go-to-market strategy, investor pitch decks, growth plans | Established pharma companies planning diversification or scale |
Conclusion: Practical Next Steps for Pharmaceutical Project Entrepreneurs
India’s pharmaceutical drugs sector is one of the most resilient, globally competitive, and policy-supported manufacturing industries in the country. For entrepreneurs entering this space — whether in API manufacturing, bulk drug intermediates, formulations, or fine chemicals — the starting point must be a technically sound, financially credible project plan. That plan begins with engaging a knowledgeable pharmaceutical drugs industry consultant who brings both process engineering depth and regulatory experience.
Start by clearly defining your project scope: which drug category, which dosage form, what manufacturing capacity (expressed in MT/TPD or million units per annum), and what target market — domestic or export. This clarity allows potential consulting firms to accurately scope their services and provide realistic timelines and cost estimates.
Next, shortlist two to three consultants based on the evaluation criteria outlined in this article — domain expertise, DPR track record, regulatory knowledge, and EPC capability. Request sample project reports or feasibility study outlines, and assess both the technical rigour and the readability of these documents from a banker or investor perspective.
Explore the range of pharmaceutical project ideas available through resources such as NPCS’s pharmaceutical project profiles catalogue at niir.org, which covers a broad spectrum of pharma manufacturing opportunities from API synthesis to speciality chemicals and drug intermediates. Use these profiles for initial project identification and comparative assessment before commissioning a full DPR.
Stay current with sector policy through the Department of Pharmaceuticals, the IBEF Pharmaceuticals Industry page, and the Invest India Pharmaceuticals sector page, which regularly publish updated scheme information, export statistics, and investment data relevant to your project planning.
Finally, engage a pharma regulatory consultant early — ideally before finalising the plant location — to understand state-specific drug controller requirements, Pollution Control Board consent processes, and any cluster or SEZ advantages available in your preferred location. The earlier you understand the regulatory pathway, the fewer surprises you encounter during project execution.
India’s pharmaceutical manufacturing opportunity is large, policy-supported, and globally aligned. With the right pharmaceutical drugs industry consultants by your side, turning that opportunity into a commissioned, compliant, and profitable manufacturing unit is an achievable goal.
